Germany
Japan
United Kingdom
China
Primary Antibodies
Download
Anti-LGR5 mouse mAb, clone OTI2A2, DyLight 488 conjugated
| Applications | FC |
| Reactivities | Human, Mouse |
| Conjugation | DyLight 488 |
Rabbit Polyclonal PD-L1 Antibody
| Applications | FC, IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | PD-L1 antibody was raised against a 17 amino acid synthetic peptide from near the center of human PD-L1. The immunogen is located within amino acids 60 - 110 of PD-L1. |
EPCAM mouse monoclonal antibody, clone 323/A3, Aff - Purified
| Applications | FC, IF, IHC, IP, WB |
| Reactivities | Human |
CD61 (ITGB3) mouse monoclonal antibody, clone VIPL2, Aff - Purified
| Applications | FC, IHC, WB |
| Reactivities | Human, Primate |
USD 399.00
In Stock
USD 430.00
2 Weeks
Carbonic Anhydrase IX (CA9) Marker mouse monoclonal antibody, clone 66.4.C2 (PN-15), Purified
| Applications | FC, IF, IHC, IP, WB |
| Reactivities | Equine, Human |
USD 240.00
2 Weeks
Carbonic Anhydrase IX (CA9) Marker mouse monoclonal antibody, clone 66.4.C2 (PN-15), Purified
| Applications | FC, IF, IHC, IP, WB |
| Reactivities | Equine, Human |
Anti-LGR5 mouse mAb, clone OTI2A2, DyLight633 conjugated
| Applications | FC |
| Reactivities | Human, Mouse |
| Conjugation | DyLight 633 |
TAPA1 (CD81) mouse monoclonal antibody, clone M38, PE
| Applications | FC |
| Reactivities | Feline, Human, Rabbit |
| Conjugation | PE |
CD130 (IL6ST) mouse monoclonal antibody, clone B-P4, Azide Free
| Applications | FC, FN, IHC, IP, WB |
| Reactivities | Human |
Rabbit polyclonal HLA-G Antibody (Center)
| Applications | FC, IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This HLA-G antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 62-89 amino acids from the Central region of human HLA-G. |
Rabbit Polyclonal Anti-Angiotensin II Receptor Type-1 (extracellular)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Peptide NSSTEDGIKRIQDDC, corresponding to amino acid residues 4-18 of human AT1 receptor. Extracellular, N-terminus. |
CD16 (FCGR3A) mouse monoclonal antibody, clone DJ130c, Purified
| Applications | FC, IHC |
| Reactivities | Human |
TAPA1 (CD81) mouse monoclonal antibody, clone M38, Purified
| Applications | FC, FN, IF, IHC, IP, WB |
| Reactivities | Feline, Human, Rabbit |
HER2 (ERBB2) Mouse Monoclonal Antibody, clone 3C2-4
| Applications | FC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
HER2 (ERBB2) Mouse Monoclonal Antibody, clone 3G11-14
| Applications | FC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
HER2 (ERBB2) Mouse Monoclonal Antibody, clone 4A5-19
| Applications | FC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
HER2 (ERBB2) Mouse Monoclonal Antibody, clone 5F4-15
| Applications | FC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
HER2 (ERBB2) Mouse Monoclonal Antibody, clone 5G12-21
| Applications | FC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
HER2 (ERBB2) Mouse Monoclonal Antibody, clone 6F5-23
| Applications | FC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
HER2 (ERBB2) Mouse Monoclonal Antibody, clone 6H8-22
| Applications | FC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
HER2 (ERBB2) Mouse Monoclonal Antibody, clone 8E8-2
| Applications | FC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
HER2 (ERBB2) Mouse Monoclonal Antibody, clone 8F6-6
| Applications | FC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
HER2 (ERBB2) Mouse Monoclonal Antibody, clone 9G5-20
| Applications | FC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
HER2 (ERBB2) Mouse Monoclonal Antibody, clone 12G4-15
| Applications | FC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
HER2 (ERBB2) Mouse Monoclonal Antibody, clone 15C4-8
| Applications | FC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
HER2 (ERBB2) Mouse Monoclonal Antibody, clone 16F12-11
| Applications | FC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
Adenosine Receptor A2a (ADORA2A) (full length) Mouse Monoclonal Antibody [Clone ID: 7F6-G5-A2 / 7F6]
USD 440.00
2 Weeks
Adenosine Receptor A2a (ADORA2A) (full length) mouse monoclonal antibody, clone 7F6-G5-A2 / 7F6, Purified
| Applications | FC, IHC, WB |
| Reactivities | Canine, Guinea Pig, Human, Mouse, Rabbit, Rat |
USD 524.00
In Stock
Rabbit Polyclonal Antibody against CD19 (N-term)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This CD19 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 143-172 amino acids from the N-terminal region of human CD19. |
Rabbit polyclonal ROR2 Antibody (N-term)
| Applications | FC, IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This ROR2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 19-50 amino acids from the N-terminal region of human ROR2. |
Rabbit Polyclonal Anti-KV11.1 (HERG) (extracellular)
| Applications | FC, IF, IHC, IP, WB |
| Reactivities | Human, Rat |
| Conjugation | Unconjugated |
| Immunogen | Peptide AFLLKETEEGPPATEC corresponding to residues 430-445 of human KV11.1 (HERG). Extracellular, between S1 and S2 domains. |
CD4 mouse monoclonal antibody, clone B-A1, Azide Free
| Applications | FC, FN, IHC |
| Reactivities | Human |
Syndecan 1 (SDC1) mouse monoclonal antibody, clone B-A38, Azide Free
| Applications | FC, IHC |
| Reactivities | Human |
Active filters
Applications
- FC
Families
- Transmembrane
Filter by
Target Symbol
- PDCD1 (198)
- CD5 (187)
- HAVCR2 (115)
- PECAM1 (97)
- CD274 (88)
- CD47 (85)
- L1CAM (85)
- ERBB2 (78)
- CTLA4 (77)
- PDCD1LG2 (77)
- CD99 (75)
- TNFRSF8 (75)
- PTPRC (70)
- CD33 (66)
- ICOS (66)
- TIGIT (66)
- LGR5 (63)
- CD40 (60)
- LAG3 (57)
- RNF144B (55)
- TNFRSF9 (55)
- CD2 (51)
- CD63 (51)
- CD80 (51)
- BTLA (50)
- NPR3 (50)
- RPN1 (50)
- CD8A (46)
- BTN1A1 (45)
- LRRC25 (45)
- CD86 (44)
- NGFR (42)
- CD19 (40)
- PTPRE (40)
- CD27 (38)
- COX6A1 (36)
- APP (35)
- CYP1A2 (35)
- HMOX2 (35)
- POR (35)
- CD14 (32)
- BSG (31)
- ENPEP (31)
- HP (31)
- TNFRSF4 (31)
- ILVBL (30)
- KCNJ3 (30)
- SLAMF7 (30)
- SSR1 (30)
- CDH2 (29)
- CD4 (28)
- TMEFF2 (27)
- FCGR3A (26)
- LYVE1 (26)
- MME (26)
- BEST3 (25)
- FCER2 (25)
- PROM1 (25)
- SIRPA (25)
- SLC7A8 (25)
- SPG7 (25)
- VSIG2 (25)
- CD28 (24)
- VSIR (24)
- FCGR1A (23)
- IL2RA (23)
- CD44 (22)
- CD70 (22)
- CD34 (21)
- IL3RA (21)
- CD38 (20)
- CDCP1 (20)
- CYP2A6 (20)
- FCGR2A (20)
- PTPN1 (20)
- SERPINB13 (20)
- SLC2A5 (20)
- SPINT1 (20)
- TMPRSS5 (20)
- TPSG1 (20)
- UBE2J1 (20)
- CD36 (19)
- CD3E (19)
- TNF (18)
- LAMP1 (17)
- TNFRSF14 (17)
- ERBB3 (16)
- FOLH1 (16)
- ABCB1 (15)
- AQP1 (15)
- CD79B (15)
- ECRG4 (15)
- GOLM1 (15)
- ITGB1 (15)
- LDLR (15)
- LMAN1 (15)
- MCL1 (15)
- MS4A1 (15)
- SIL1 (15)
- TMEM230 (15)
Reactivities
Antibody Hosts
Isotypes
Clonalities
Conjugates
Knockout (KO) Validation
Pathways
- Cell adhesion molecules (CAMs) (1357)
- Hematopoietic cell lineage (807)
- Cytokine-cytokine receptor interaction (580)
- T cell receptor signaling pathway (554)
- Primary immunodeficiency (341)
- Systemic lupus erythematosus (275)
- Autoimmune thyroid disease (272)
- Toll-like receptor signaling pathway (239)
- Leukocyte transendothelial migration (238)
- Metabolic pathways (229)
- Allograft rejection (214)
- Viral myocarditis (210)
- Pathways in cancer (179)
- ECM-receptor interaction (167)
- Graft-versus-host disease (153)
- Calcium signaling pathway (152)
- Type I diabetes mellitus (150)
- Focal adhesion (144)
- Fc gamma R-mediated phagocytosis (140)
- Adherens junction (135)
- Prostate cancer (124)
- Endocytosis (122)
- Alzheimer's disease (119)
- Natural killer cell mediated cytotoxicity (117)
- Axon guidance (111)
- Regulation of actin cytoskeleton (106)
- ErbB signaling pathway (103)
- Antigen processing and presentation (96)
- Bladder cancer (94)
- Endometrial cancer (91)
- Asthma (88)
- MAPK signaling pathway (87)
- Non-small cell lung cancer (86)
- Pancreatic cancer (86)
- Lysosome (84)
- B cell receptor signaling pathway (80)
- Apoptosis (78)
- Jak-STAT signaling pathway (73)
- Renin-angiotensin system (68)
- Parkinson's disease (63)
- Pathogenic Escherichia coli infection (60)
- Drug metabolism - cytochrome P450 (57)
- Caffeine metabolism (56)
- Retinol metabolism (56)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (55)
- N-Glycan biosynthesis (52)
- Neurotrophin signaling pathway (52)
- Linoleic acid metabolism (47)
- Neuroactive ligand-receptor interaction (47)
- Dilated cardiomyopathy (45)
- Hypertrophic cardiomyopathy (HCM) (44)
- Adipocytokine signaling pathway (41)
- Huntington's disease (40)
- Tryptophan metabolism (40)
- Cardiac muscle contraction (39)
- Colorectal cancer (39)
- Oxidative phosphorylation (38)
- Porphyrin and chlorophyll metabolism (38)
- Complement and coagulation cascades (36)
- Melanoma (36)
- Metabolism of xenobiotics by cytochrome P450 (36)
- Glioma (31)
- Amyotrophic lateral sclerosis (ALS) (29)
- Chemokine signaling pathway (28)
- Gap junction (27)
- Small cell lung cancer (26)
- RIG-I-like receptor signaling pathway (25)
- PPAR signaling pathway (24)
- Nicotinate and nicotinamide metabolism (23)
- ABC transporters (22)
- Drug metabolism - other enzymes (22)
- Fc epsilon RI signaling pathway (22)
- Insulin signaling pathway (22)
- NOD-like receptor signaling pathway (21)
- Ubiquitin mediated proteolysis (20)
- Olfactory transduction (18)
- TGF-beta signaling pathway (18)
- Type II diabetes mellitus (18)
- Epithelial cell signaling in Helicobacter pylori infection (15)
- Long-term depression (13)
- Nitrogen metabolism (13)
- Androgen and estrogen metabolism (12)
- Arachidonic acid metabolism (12)
- Progesterone-mediated oocyte maturation (12)
- Vascular smooth muscle contraction (12)
- Oocyte meiosis (11)
- GnRH signaling pathway (10)
- Tight junction (10)
- Vibrio cholerae infection (10)
- Glutathione metabolism (9)
- Dorso-ventral axis formation (8)
- Melanogenesis (8)
- Purine metabolism (8)
- p53 signaling pathway (8)
- Acute myeloid leukemia (7)
- Glycosphingolipid biosynthesis - lacto and neolacto series (7)
- Biosynthesis of unsaturated fatty acids (6)
- Fatty acid metabolism (6)
- Keratan sulfate biosynthesis (6)
- Prion diseases (6)
- Thyroid cancer (6)
- beta-Alanine metabolism (6)
- Arginine and proline metabolism (5)
- Ascorbate and aldarate metabolism (5)
- Butanoate metabolism (5)
- Glycerolipid metabolism (5)
- Glycolysis / Gluconeogenesis (5)
- Histidine metabolism (5)
- Limonene and pinene degradation (5)
- Lysine degradation (5)
- Propanoate metabolism (5)
- Pyruvate metabolism (5)
- Riboflavin metabolism (5)
- Valine (5)
- leucine and isoleucine degradation (5)
- O-Glycan biosynthesis (4)
- Cytosolic DNA-sensing pathway (3)
- Glycerophospholipid metabolism (3)
- Heparan sulfate biosynthesis (3)
- Starch and sucrose metabolism (3)
- alpha-Linolenic acid metabolism (3)
- Basal cell carcinoma (2)
- Ether lipid metabolism (2)
- Notch signaling pathway (2)
- Pantothenate and CoA biosynthesis (2)
- Pyrimidine metabolism (2)
- SNARE interactions in vesicular transport (2)
- Sphingolipid metabolism (2)
- Taste transduction (2)
- Tyrosine metabolism (2)
- Wnt signaling pathway (2)
- Glycine (1)
- Glycosaminoglycan degradation (1)
- Glycosylphosphatidylinositol(GPI)-anchor biosynthesis (1)
- Hedgehog signaling pathway (1)
- Long-term potentiation (1)
- O-Mannosyl glycan biosynthesis (1)
- Pentose and glucuronate interconversions (1)
- Phenylalanine metabolism (1)
- Primary bile acid biosynthesis (1)
- VEGF signaling pathway (1)
- serine and threonine metabolism (1)